Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | TTR | P02766 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29430520 | 1.00 | MAPT (0.66) | MAPTHCAR2ALDH1A1ATMNPSR1 | |
| SCHEMBL265418 | 1.00 | MAPT (0.66) | MAPTHCAR2ALDH1A1ATMNPSR1 | |
| Ethylene SCHEMBL27926804 | 0.96 | MAPT (0.61) | MAPTHCAR2ALDH1A1ATMNPSR1 | |
| (2E)-Hexenoic Acid SCHEMBL28617152 | 0.94 | HCAR2 (0.67) | MAPTHCAR2ALDH1A1ATMNPSR1 | |
| (2E)-Hexenoic Acid SCHEMBL451892 | 0.94 | HCAR2 (0.67) | MAPTHCAR2ALDH1A1ATMNPSR1 | |
| Trimethylammonium SCHEMBL27821912 | 0.94 | MAPT (0.59) | MAPTHCAR2ALDH1A1ATMNPSR1 | |
| SCHEMBL4582863 | 0.92 | MAPT (0.73) | MAPTHCAR2ALDH1A1ATMTTR | |
| SCHEMBL4936379 | 0.92 | MAPT (0.73) | MAPTHCAR2ALDH1A1ATMTTR | |
| SCHEMBL4933994 | 0.92 | MAPT (0.68) | MAPTHCAR2ALDH1A1ATMCYP3A4 | |
| SCHEMBL4582673 | 0.92 | MAPT (0.68) | MAPTHCAR2ALDH1A1ATMCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354180-A1 | ENZYMES, CELLS, AND METHODS FOR PRODUCING CIS-3 HEXENOL | MANUS BIO INC (US) | 2025-11-20 | — | — | US | claimed |
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| US-12350136-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | claimed |
| CN-119257226-A | Traditional fermented chopped chilli altar-flavor compound and preparation method and application thereof | 湖南农业大学 | 2025-01-07 | — | — | CN | claimed |
| US-20240306688-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2024-09-19 | — | — | US | claimed |
| EP-4391827-A1 | METHOD OF MITIGATING OFF-ODORS | Givaudan SA (CH) | 2024-07-03 | — | — | EP | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| CN-117897055-A | Method for reducing abnormal odor | 奇华顿股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| WO-2023220728-A2 | ENZYMES, CELLS, AND METHODS FOR PRODUCING CIS-3 HEXENOL | MANUS BIO INC. (US) | 2023-11-16 | — | — | WO | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| WO-2018048852-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-15 | — | — | WO | claimed |
| US-20180064588-A1 | Absorbent Articles Including Perfume and Cyclodextrins | THE PROCTER & GAMBLE COMPANY | 2018-03-08 | — | — | US | claimed |
| US-20080311054-A1 | Compositions and Methods to Counteract Oral Malodour | GIVAUDAN SA (CH) | 2008-12-18 | — | — | US | claimed |
| US-20080247966-A1 | Compositions and Methods to Counteract Oral Malodour | GIVAUDAN SA (CH) | 2008-10-09 | — | — | US | claimed |
| EP-1937365-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | Givaudan SA (CH) | 2008-07-02 | — | — | EP | claimed |
| EP-1919566-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | Givaudan SA (CH) | 2008-05-14 | — | — | EP | claimed |
| WO-2007025401-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | GIVAUDAN SA (CH) | 2007-03-08 | — | — | WO | claimed |
| WO-2007025402-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | GIVAUDAN SA (CH) | 2007-03-08 | — | — | WO | claimed |
| WO-2002033404-A2 | INTEGRATED WINE QUALITY SENSOR | TRAUNER KENNETH B (US) | 2002-04-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311054-A1 | Compositions and Methods to Counteract Oral Malodour | TAS2R60, TAS2R40, LPO | MAPT 3014/4885HCAR2 1404/4885ALDH1A1 1466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.